| Dr Charles Andrew Parrish, | |
|
3918 Montclair Rd, Suite 105, Mountain Brk, AL 35213-2425 | |
| (205) 705-3550 | |
| (205) 705-3554 |
| Full Name | Dr Charles Andrew Parrish |
|---|---|
| Gender | Male |
| Speciality | Pathology |
| Experience | 23 Years |
| Location | 3918 Montclair Rd, Mountain Brk, Alabama |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164646238 | NPI | - | NPPES |
| 51136307 | Other | AL | BLUE CROSS |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Associated Pathologists Llc | 0648167544 | 103 |
News Archive
When a gene is switched on, various stretches of DNA nearby act as 'control dials', influencing the level of activity and the amount of gene product that is made.
Trius Therapeutics, Inc. announced today the issuance of Patent Number 7,816,379, entitled "Oxazolidinone Derivatives," by the United States Patent and Trademark Office (USPTO). The new patent, which is exclusively licensed to Trius, protects the Company's lead investigational drug, torezolid phosphate (TR-701), currently in Phase 3 clinical testing in patients with acute bacterial skin and skin structure infections (ABSSSI).
Gov. Bill Haslam said he wants to expand health insurance coverage for low-income residents, but "on his own terms" by enrolling large numbers in private insurance plans.
Older people and people with underlying medical conditions are at particular risk of severe COVID-19. A group of researchers from Charité - Universitätsmedizin Berlin have discovered one possible reason for this vulnerability.
Cocaine continues to be one of the most commonly abused illicit drugs in the United States. Pre-clinical literature suggests that targeting glucagon-like peptide-1 receptors (GLP-1Rs) in the brain may represent a novel approach to treating cocaine use disorder.
› Verified 8 days ago
| Entity Name | Dermlab Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164764528 PECOS PAC ID: 7810137213 Enrollment ID: O20130709000727 |
News Archive
When a gene is switched on, various stretches of DNA nearby act as 'control dials', influencing the level of activity and the amount of gene product that is made.
Trius Therapeutics, Inc. announced today the issuance of Patent Number 7,816,379, entitled "Oxazolidinone Derivatives," by the United States Patent and Trademark Office (USPTO). The new patent, which is exclusively licensed to Trius, protects the Company's lead investigational drug, torezolid phosphate (TR-701), currently in Phase 3 clinical testing in patients with acute bacterial skin and skin structure infections (ABSSSI).
Gov. Bill Haslam said he wants to expand health insurance coverage for low-income residents, but "on his own terms" by enrolling large numbers in private insurance plans.
Older people and people with underlying medical conditions are at particular risk of severe COVID-19. A group of researchers from Charité - Universitätsmedizin Berlin have discovered one possible reason for this vulnerability.
Cocaine continues to be one of the most commonly abused illicit drugs in the United States. Pre-clinical literature suggests that targeting glucagon-like peptide-1 receptors (GLP-1Rs) in the brain may represent a novel approach to treating cocaine use disorder.
› Verified 8 days ago
| Entity Name | Associated Pathologists Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003863580 PECOS PAC ID: 0648167544 Enrollment ID: O20210521000436 |
News Archive
When a gene is switched on, various stretches of DNA nearby act as 'control dials', influencing the level of activity and the amount of gene product that is made.
Trius Therapeutics, Inc. announced today the issuance of Patent Number 7,816,379, entitled "Oxazolidinone Derivatives," by the United States Patent and Trademark Office (USPTO). The new patent, which is exclusively licensed to Trius, protects the Company's lead investigational drug, torezolid phosphate (TR-701), currently in Phase 3 clinical testing in patients with acute bacterial skin and skin structure infections (ABSSSI).
Gov. Bill Haslam said he wants to expand health insurance coverage for low-income residents, but "on his own terms" by enrolling large numbers in private insurance plans.
Older people and people with underlying medical conditions are at particular risk of severe COVID-19. A group of researchers from Charité - Universitätsmedizin Berlin have discovered one possible reason for this vulnerability.
Cocaine continues to be one of the most commonly abused illicit drugs in the United States. Pre-clinical literature suggests that targeting glucagon-like peptide-1 receptors (GLP-1Rs) in the brain may represent a novel approach to treating cocaine use disorder.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Charles Andrew Parrish, 1010 Airpark Center Dr, Nashville, TN 37217-5200 Ph: (615) 221-4400 | Dr Charles Andrew Parrish, 3918 Montclair Rd, Suite 105, Mountain Brk, AL 35213-2425 Ph: (205) 705-3550 |
News Archive
When a gene is switched on, various stretches of DNA nearby act as 'control dials', influencing the level of activity and the amount of gene product that is made.
Trius Therapeutics, Inc. announced today the issuance of Patent Number 7,816,379, entitled "Oxazolidinone Derivatives," by the United States Patent and Trademark Office (USPTO). The new patent, which is exclusively licensed to Trius, protects the Company's lead investigational drug, torezolid phosphate (TR-701), currently in Phase 3 clinical testing in patients with acute bacterial skin and skin structure infections (ABSSSI).
Gov. Bill Haslam said he wants to expand health insurance coverage for low-income residents, but "on his own terms" by enrolling large numbers in private insurance plans.
Older people and people with underlying medical conditions are at particular risk of severe COVID-19. A group of researchers from Charité - Universitätsmedizin Berlin have discovered one possible reason for this vulnerability.
Cocaine continues to be one of the most commonly abused illicit drugs in the United States. Pre-clinical literature suggests that targeting glucagon-like peptide-1 receptors (GLP-1Rs) in the brain may represent a novel approach to treating cocaine use disorder.
› Verified 8 days ago
Dr. Jenny Oakes Sobera, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2900 Cahaba Rd, Mountain Brk, AL 35223 Phone: 205-877-9773 Fax: 205-877-9775 | |
Michael Keith Jacobs, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3918 Montclair Rd, Suite 105, Mountain Brk, AL 35213 Phone: 205-705-3550 Fax: 205-705-3554 | |
Julia Tauscher, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2900 Cahaba Rd, Mountain Brk, AL 35223 Phone: 205-877-9773 Fax: 205-877-9775 | |
Caroline Crabtree, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2900 Cahaba Rd, Mountain Brk, AL 35223 Phone: 205-877-9773 Fax: 205-877-9775 | |
Stephen E. Mason, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3918 Montclair Rd, Suite 105, Mountain Brk, AL 35213 Phone: 205-705-3550 Fax: 205-705-3554 | |
Dr. Rachel Teat Pflederer, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2900 Cahaba Rd, Mountain Brk, AL 35223 Phone: 205-877-9773 Fax: 205-877-9775 |